fentanyl and midazolam

ApprovedSmall molecule

NNorwegian University of Science and Technology

fentanyl and midazolam is one of 16 small molecule programs targeting Hypothermia. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HypothermiaActive, not recruiting

HypothermiaApproved

Active, not recruiting

Competition

Competitive Landscape

20 competitors in Hypothermia

#DrugCompanyPhaseTrials

Bridion

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Approved

1 2

Paracetamol

GSK

Approved

1 3

Cortef

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

2 4

Epsom Salt

FFresenius Kabi Oncology Ltd.

Phase 3

1 5

Xe-133

NNobilis Therapeutics Inc.

Phase 2

1 6

Enbrel

IImmunex

Phase 2

1 7

fentanyl and midazolam

NNorwegian University of Science and Technology

Approved

1 8

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 1

1 9

Circadin

NNeurim Pharmaceuticals Ltd.

Phase 1

—10

Neuromuscular Blocking Agents

UUniversity of Maryland, Baltimore

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hypothermia1 trial

Remifentanil and Propofol Versus Fentanyl and Midazolam for Sedation During Therapeutic Hypothermia. A Randomised, Controlled Trial

Completed·NNorwegian University of Science and Technology·Phase 4·NCT00667043·60 enrolled

Premedication1 trial

Premedication on Sevoflurane Induction

Completed·MMaisonneuve-Rosemont Hospital·N/A·NCT00723164·80 enrolled

Intensive Care Unit1 trial

Comparison of Morphine and Fentanyl/Midazolam in Intensive Care Unit

Completed·CClínica de Los Andes IPS·N/A·NCT01602640·90 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for fentanyl and midazolam. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — fentanyl and midazolam compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for fentanyl and midazolam. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Norwegian University of Science and Technology company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: NNorwegian University of Science and Technology

fentanyl and midazolam

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hypothermia1 trial

Premedication1 trial

Intensive Care Unit1 trial

References

Drug Info

Quick Facts

Related News